Veru

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. 

CEO
Mitchell Shuster Steiner
CEOMitchell Shuster Steiner
Employees
20
Employees20
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
1971
Founded1971
Employees
20
Employees20

VERU Key Statistics

Market cap
38.52M
Market cap38.52M
Price-Earnings ratio
-1.97
Price-Earnings ratio-1.97
Dividend yield
Dividend yield
Average volume
60.27K
Average volume60.27K
High today
$2.46
High today$2.46
Low today
$2.36
Low today$2.36
Open price
$2.46
Open price$2.46
Volume
29.52K
Volume29.52K
52 Week high
$7.40
52 Week high$7.40
52 Week low
$2.10
52 Week low$2.10

Stock Snapshot

The current Veru(VERU) stock price is $2.39, with a market capitalization of 38.52M. The stock trades at a price-to-earnings (P/E) ratio of -1.97.

During the trading session on 2026-03-15, Veru(VERU) shares reached a daily high of $2.46 and a low of $2.36. At a current price of $2.39, the stock is +1.3% higher than the low and still -2.8% under the high.

Trading volume for Veru(VERU) stock has reached 29.52K, versus its average volume of 60.27K.

Over the past 52 weeks, Veru(VERU) stock has traded between a high of $7.40 and a low of $2.10.

Over the past 52 weeks, Veru(VERU) stock has traded between a high of $7.40 and a low of $2.10.

VERU News

TipRanks 5d
Veru Targets GLP-1 Muscle Loss Risk With New Enobosarm Combo Study

Veru Inc (VERU) announced an update on their ongoing clinical study. Veru Inc. is launching a Phase 2b proof of concept trial called PLATEAU to test whether ad...

TipRanks 6d
Veru enrolls first patient in Phase 2b PLATEAU trial of enobosarm

Veru (VERU) announced that it has enrolled the first patient in its Phase 2b PLATEAU clinical trial of enobosarm, an oral selective androgen receptor modulator,...

People also own

Based on the portfolios of people who own VERU. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.